ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,026Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 2343

$978K Total Retail Price of All Prescriptions

Rank: 138 out of 2343

916 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 916 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 916 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 16,342 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 940 735 1 8
LEVOTHYROXINE SODIUM 677 624 2 2
FUROSEMIDE 615 538 3 6
SIMVASTATIN 596 518 4 1
DONEPEZIL HCL 464 464 5 21
LISINOPRIL 427 406 6 3
MIRTAZAPINE 422 379 7 41
METOPROLOL TARTRATE 416 389 8 7
OMEPRAZOLE 380 347 9 4
SERTRALINE HCL 378 349 10 20
CITALOPRAM HBR 374 312 11 17
AMLODIPINE BESYLATE 360 316 12 5
NAMENDA 309 309 13 36
GABAPENTIN 271 221 14 16
HYDROCODONE-ACETAMINOPHEN 266 227 S3 15 13
TRAZODONE HCL 254 206 16 53
POTASSIUM CHLORIDE 252 252 17 18
POLYETHYLENE GLYCOL 3350 239 232 18 54
QUETIAPINE FUMARATE 232 208 19 77
IPRATROPIUM-ALBUTEROL 229 104 20 99
ATENOLOL 210 197 21 12
PANTOPRAZOLE SODIUM 196 188 22 22
KLOR-CON M20 179 149 23 44
TAMSULOSIN HCL 178 153 24 29
ATORVASTATIN CALCIUM 172 148 25 10
LANTUS SOLOSTAR 158 114 26 101
CARVEDILOL 158 125 26 27
LEVETIRACETAM 155 139 28 104
ISOSORBIDE MONONITRATE ER 152 149 29 32
CLOPIDOGREL 150 132 30 26
ADVAIR DISKUS 148 111 31 34
RISPERIDONE 147 142 32 61
ALBUTEROL SULFATE 134 85 33 126
FAMOTIDINE 130 104 34 60
ALENDRONATE SODIUM 129 114 35 28
ESCITALOPRAM OXALATE 126 105 36 55
HUMALOG 124 96 37 131
DIOVAN 122 107 38 23
PLAVIX 118 109 39 38
FLUTICASONE PROPIONATE 114 102 40 46
METFORMIN HCL 111 86 41 9
SPIRONOLACTONE 110 87 42 65
OXYCODONE HCL 107 68 S2 43 67
DIVALPROEX SODIUM 104 72 44 105
DIGOXIN 100 99 45 35
HYDROCHLOROTHIAZIDE 99 79 46 11
SEROQUEL 99 82 46 171
PREDNISONE 97 84 48 37
CEPHALEXIN 95 69 49 111
CELEBREX 94 86 50 71
DILTIAZEM 24HR CD 90 89 51 83
TRAMADOL HCL 87 81 52 25
LANTUS 87 72 52 51
SPIRIVA 86 66 54 48
FENTANYL 86 86 S2 54 69
KLOR-CON M10 85 68 56 107
AGGRENOX 80 80 57 174
SANTYL 80 39 57 195
CARBIDOPA-LEVODOPA 79 79 59 85
LOSARTAN POTASSIUM 79 75 59 19
LEVOFLOXACIN 77 66 61 106
FINASTERIDE 76 71 62 80
NITROFURANTOIN MONO-MACRO 73 66 63 244
NOVOLOG 72 63 64 110
EXELON 72 72 64 129
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 57 66 120
OLANZAPINE 70 67 66 121
RANITIDINE HCL 68 39 68 43
ONDANSETRON HCL 66 63 69 273
CYMBALTA 65 54 70 74
GLIPIZIDE 64 62 71 56
OXYCODONE-ACETAMINOPHEN 61 58 S2 72 49
PAROXETINE HCL 59 55 73 66
SODIUM CHLORIDE 59 39 73 355
ZOLPIDEM TARTRATE 59 49 73 24
NOVOLIN R 58 40 76 227
FLUOXETINE HCL 58 58 76 82
CIPROFLOXACIN HCL 58 43 76 72
OXYBUTYNIN CHLORIDE ER 57 57 79 149
MELOXICAM 57 51 79 68
TRANSDERM-SCOP 55 38 81 362
ZETIA 53 52 82 52
DOXYCYCLINE HYCLATE 52 43 83 180
ENOXAPARIN SODIUM 52 18 83 203
BACLOFEN 52 39 83 161
JANUVIA 51 50 86 50
SINGULAIR 51 38 86 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.